- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00122369
Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Large core image-guided breast biopsy is a well established tool for diagnosing breast cancer. Using ultrasound or X-ray guidance, a large hollow needle is inserted through the skin into the breast and abnormal tissue is removed for diagnosis. Although this procedure is much less invasive than open surgery, it can induce pain and anxiety that can tax the coping mechanism of even the highest functioning individuals. Unrelieved stress during a medical procedure not only interferes with smooth progression of the ongoing procedure, but can also have deleterious effects when patients need additional procedures and feel dread in anticipation. The long-term objective of this research is to provide patients with a simple coping strategy at the time of large core biopsy, when they need it most. The hope is that this newly learned ability to handle distress will carry over to recovery and to future medical procedures. In a prior clinical trial (Lancet 2000:335:1486-1489), the largest prospective randomized study of its kind, the researchers showed that a self-hypnotic intervention during image-guided interventions of the blood vessels and the kidneys resulted in less pain and anxiety, fewer worrisome increases and decreases of blood pressure and heart rate, and fewer procedure interruptions. The positive effects of the short initial hypnotic intervention, which was structured in the procedure room, became more pronounced the longer the procedure lasted and carried over into the immediate post-procedure recovery. Based on these past findings, the researchers therefore predict to show evidence contrary to the current thinking that long-lasting effects require intensive presurgical preparation.
The researchers propose to pursue three interrelated specific aims:
- (Aim 1): Determine the acute effects of self-hypnotic relaxation on pain and anxiety. Strictly defined methods of self-hypnotic relaxation (Group I), will be tested against empathic attention (Group II) and the routine standard of care (Group III) in a prospective randomized study with 240 patients undergoing large core breast biopsy. The impact of the treatment will be validated by comparing during the procedure among groups subjective measures of pain and anxiety as well as objective physiologic indicators of pain and anxiety (frequency of significant increases in heart rate and blood pressure).
- (Aim 2): Determine the delayed effects of self-hypnotic relaxation. Patients' levels of pain, anxiety, and stress will be recorded through days 1-5 after the biopsy and compared among groups. Stress levels measurements will be based on an objective test (the amount of the stress hormone cortisol in the patient's saliva).
- (Aim 3): Determine the effect of the initial self-hypnotic relaxation on distress with upcoming subsequent surgery in women with proven breast cancer. When patients have to return for surgery because their biopsy revealed malignant cells, they will be given questionnaires assessing their degree of perceived stress , anxiety, and preoccupation with their upcoming surgery. Comparison among groups will show the durability of the initial hypnotic intervention.
The researchers hypothesize that:
- Self-hypnotic relaxation reduces pain and anxiety during large core breast biopsy
- Self-hypnotic relaxation at the time of biopsy reduces post-biopsy stress
- Teaching patients coping skills at the critical time of the breast biopsy reduces the patients' distress with upcoming breast surgery.
Upon completion, a short periprocedural self-hypnotic intervention will be validated by rigorous and practical assessment in 240 patients. The relative performance of self-hypnotic relaxation will be known compared to standard care and empathic controls in a well-characterized population of patients with a standardized biopsy wound. The durability of an intervention given at the earliest possible moment of breast cancer diagnosis will be established. This opens the way to future study designs addressing long-term effects on health behavior and psycho-physiologic phenomena.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients presenting for large core breast biopsy in the Radiology Department at the Beth Israel Deaconess Medical Center Boston.
Exclusion Criteria:
Patients are excluded if :
- They are unable to give informed consent, or pass screening for impaired mental function or psychosis.
- They are unable to hear or understand English.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Self-hypnotic Relaxation
A research assistant displayed defined behaviors of empathic attention and read to the patient a self-hypnotic relaxation script.
Patients also received lidocaine as local anesthetic which is the standard care approach and not considered a unique intervention in terms of the trial.
|
A research assistant read to the patient a self-hypnotic relaxation script while displaying empathic attention.
Other Names:
A research assistant displayed defined behaviors of empathic attention.
Other Names:
|
No Intervention: Standard Care
Patients received the routine standard treatment which included application of lidocaine as local anesthetic.
This is not considered a unique intervention in terms of the trial.
Omitting local anesthetic actually would have been an intervention deviating from routine care.
|
|
Active Comparator: Empathic Attention
A research assistant displayed defined behaviors of empathic attention.
Patients also received lidocaine as local anesthetic which is the standard care approach and not considered a unique intervention in terms of the trial.
|
A research assistant displayed defined behaviors of empathic attention.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 0 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety to 10=worst possible anxiety.
Patients self-reported anxiety at the beginning (time 0), every 10 minutes, and at the end of their biopsy procedure on a 0-10 numeric verbal anxiety scale (0=no anxiety at all, 10=worst possible anxiety).
Participants were followed for the duration of the biopsy procedure, an average of 43 min.
|
0 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 10 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
10 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 20 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
20 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 30 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
30 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 40 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
40 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 50 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
50 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 60 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
60 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 70 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
70 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 80 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
80 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 90 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
90 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 100 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
100 min
|
Anxiety Ratings at Specified Time Point During the Procedure
Time Frame: 110 min
|
Self-reported anxiety on a scale of 0-10 with 0=no anxiety and 10=worst possible anxiety
|
110 min
|
Time Trends of Anxiety Experience
Time Frame: 0-110 min
|
Ordinal regression analysis looks at data as a series of possible splits of patient responses and assesses the odds of experiencing a value at or above as compared to the split; e.g. the probability of experiencing self-reported anxiety scores of 0 vs 1-10; 0-2 vs 3-10 ; 0-4 vs 5-10 etc with anxiety scores reported between 0=no anxiety and 10=worst possible anxiety.
The summary analysis with logit slopes gives in the time trend estimate the cumulative probabilities of the response categories over the variable N=procedure time (min).
Positive slopes indicate increasing scores above the split point over time, negative slopes indicate decreasing scores, and flat lines no significant change.
In the proportional odds model, an encompassing slope - a probability function of linear trend - is generated that not only applies to the logit forms of the individual splits but to the logic forms of graphs that portray all other splits.
The resultant slopes then facilitate comparison among groups.
|
0-110 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 0 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
0 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 10 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
10 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 20 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
20 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 30 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
30 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 40 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
40 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 50 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
50 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 60 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
60 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 70 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
70 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 80 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
80 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 90 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
90 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 100 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
100 min
|
Pain Ratings at Specified Time Point During the Procedure
Time Frame: 110 min
|
Self-reported pain on a scale of 0-10 with 0=no pain at all and 10=worst possible pain
|
110 min
|
Time Trends of Pain Experience
Time Frame: 0-110 min
|
Ordinal regression analysis looks at data as a series of possible splits of patient responses and assesses the odds of experiencing a value at or above as compared to the split; e.g. the probability of experiencing self-reported pain scores of 0 vs 1-10; 0-2 vs 3-10 ; 0-4 vs 5-10 etc with pain scores reported between 0=no pain, and 10=worst possible pain.
The summary analysis with logit slopes gives in the time trend estimate the cumulative probabilities of the response categories over the variable N=procedure time (min).
Positive slopes indicate increasing scores above the split point over time, negative slopes indicate decreasing scores, and flat lines no significant change.
In the proportional odds model, an encompassing slope - a probability function of linear trend - is generated that not only applies to the logit forms of the individual splits but to the logic forms of graphs that portray all other splits.
The resultant slopes then facilitate comparison among groups.
|
0-110 min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Salivary Cortisol Secretion
Time Frame: Patients were followed for the 5 days following their breast biopsy
|
Secretion of cortisol over time is customarily described in terms of a slope with the time of day of cortisol measurement as the x variable and the natural logarithm of the measured cortisol concentration as the y variable.
Cortisol slope is expressed as the natural logarithm of cortisol (micrograms per deciliter) per hour, with 1g/dL corresponding to 27.8 nmol/L.
In general, greater negative slopes (with steeper decreases from high morning values to low evening values) are considered better adapted and healthier than flatter (less negative) slopes.
|
Patients were followed for the 5 days following their breast biopsy
|
Impact of Event Scale (IES-15)
Time Frame: Patients were followed for up to 3 weeks after their biopsy until the time of their surgery
|
The IES is a measure of subjective distress for any specific life event. This 15-item self-report instrument is used to assess experiences of intrusive thoughts (Intrusion subscale) and attempts to consciously avoid such experiences (Avoidance subscale) that are commonly associated with subjective distress about life situations. Answers are given in four ratings from not at all (score 0) to often (score 5), with a possible TOTAL overall range of scores from zero to 75. ≥26 indicates moderate to severe distress) of women who at the time of return for breast surgery after their initial biopsy |
Patients were followed for up to 3 weeks after their biopsy until the time of their surgery
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Elvira V Lang, MD, Beth Israel Deaconess Medical Center
Publications and helpful links
General Publications
- Lang EV, Berbaum KS, Lutgendorf SK. Large-core breast biopsy: abnormal salivary cortisol profiles associated with uncertainty of diagnosis. Radiology. 2009 Mar;250(3):631-7. doi: 10.1148/radiol.2503081087.
- Lang EV, Berbaum KS, Faintuch S, Hatsiopoulou O, Halsey N, Li X, Berbaum ML, Laser E, Baum J. Adjunctive self-hypnotic relaxation for outpatient medical procedures: a prospective randomized trial with women undergoing large core breast biopsy. Pain. 2006 Dec 15;126(1-3):155-64. doi: 10.1016/j.pain.2006.06.035. Epub 2006 Sep 7.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DAMD 17-01-1-0153
- 2001P-001681
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
Clinical Trials on Self-hypnotic Relaxation
-
National Center for Complementary and Integrative...CompletedUterine Neoplasms | LeiomyomaUnited States
-
National Center for Complementary and Integrative...Completed
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Baylor UniversityNational Institutes of Health (NIH); National Center for Complementary and...CompletedHot FlashesUnited States
-
Spectrum Health HospitalsHelen DeVos Children's HospitalCompleted
-
University Hospital, Clermont-FerrandTerminatedIdiopathic Parkinson's DiseaseFrance
-
Hypnalgesics, LLCBoston Medical Center; Ohio State University; Tufts Medical CenterCompletedClaustrophobia | Complication of Diagnostic ProcedureUnited States
-
University of MichiganBreast Cancer Research FoundationCompletedCervical Cancer | Breast Cancer | Ovarian Cancer | Uterine CancerUnited States
-
Hypnalgesics, LLCDuke University; Ohio State UniversityCompletedClaustrophobia | Complication of Diagnostic ProcedureUnited States
-
Hypnalgesics, LLCCambridge Health AllianceWithdrawnDental Anxiety | Dental Pain | Root Work